ITEM 7.01 REGULATION FD DISCLOSURE
On January 26, 2022, Zymeworks Inc. ("Zymeworks" or the "Company") issued a
press release announcing the filing of a preliminary prospectus supplement in
connection with its underwritten public offering of the Company's common shares
and, in lieu of common shares to certain investors, pre-funded warrants to
purchase common shares (the "Offering"), which was filed with the Canadian
securities regulatory authorities in Canada on the System for Electronic
Document Analysis and Retrieval ("SEDAR") at www.sedar.com (the "Launch Press
Release"). Additionally, on January 26, 2022, Zymeworks issued a press release
announcing the pricing of the Offering, which was filed with the Canadian
securities regulatory authorities in Canada on SEDAR (the "Pricing Press
Release"). On January 27, 2022, copies of the Launch Press Release and the
Pricing Press Release were furnished to the Securities Exchange Commission (the
"SEC") on a Form 8-K.
Subsequently, on January 31, 2022, Zymeworks issued a press release announcing
the closing of the Offering and the exercise in full of the underwriters' option
to purchase 1,875,000 additional common shares, which was filed with the
Canadian securities regulatory authorities in Canada on SEDAR (the "Closing
Press Release"). A copy of the Closing Press Release is attached as Exhibit 99.1
hereto.
The information provided under this Item (including Exhibit 99.1, attached
hereto) shall not be deemed "filed" for purposes of Section 18 of the Securities
Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the
liabilities of that section, nor shall it be deemed incorporated by reference in
any filing under the Securities Act of 1933, as amended, or the Exchange Act,
except as expressly set forth by specific reference in such a filing.
ITEM 8.01 OTHER EVENTS
On January 31, 2022, Zymeworks filed a material change report regarding the
launch, pricing and closing of the Offering, as described in the Launch Press
Release, the Pricing Press Release and the Closing Press Release, with the
Canadian securities regulatory authorities. A copy of this material change
report is attached as Exhibit 99.2 hereto.
ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS
(d) Exhibits
Exhibit
No. Description
99.1 Press Release issued by Zymeworks Inc. on January 31, 2022
99.2 Material Change Report dated January 31, 2022
104 Cover Page Interactive Data File (embedded as Inline XBRL document)
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses